Skin Infections

Kish TD, Chang MH, Fung HB. Treatment of skin and soft tissue infections in the elderly: A review. Am J Geriatr Pharmacother. 2010;8(6):485-513.

Compton GA. Bacterial Skin and Soft Tissue Infections in Older Adults. Clinics in Geriatric Medicine. 2013;29(2):443-59.

Martini FH, Timmons MJ, Tallitsch RB. Human Anatomy. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2003:86–106.

Diggory P, Homer A, Liddle J, et al. Medicine in the elderly. Postgrad Med J. 1991;67:423–45.

Htwe TH, Mushtaq A, Robinson SB, et al. Infection in the elderly. Infect Dis Clin North Am. 2007;21:711–743.

Cassel CK, Larson EB, Meier DE, et al, eds. Geriatric Medicine: An Evidence-Based Approach. 4th ed. New York, NY: Springer; 2003:869–82.

Norman RA. Geriatric dermatology. Dermatol Ther. 2003;16:260–68.

O’Donnell JA, Hofman MT. Skin and soft tissues. Management of four common infections in the nursing home patient. Geriatrics. 2001;56:33–38, 41.

Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev. 1996;9:1–17.

Rousseau P. Immobility in the aged. Arch Fam Med. 1993;2:166–177.

Stevens DL, Bisno AL, Chambers HF, et al, for the Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue

infections [published corrections appear in Clin Infect Dis. 2006;42:1219 and Clin Infect Dis. 2005;41:1830]. Clin Infect Dis. 2005;41:1373–1406.

Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008;19:173–84.

Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs. 2003;63:1459–80.

Sachdeva MP, Tomecki KJ. Cellulitis and Erysipelas. In: Schlossberg D, ed. Clinical Infectious Disease. Cambridge, Mass; New York, NY: Cambridge University Press; 2008;151–56.

Falagas ME, Matthaiou DK, Vardakas KZ. Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: A meta-analysis of randomized controlled trials. Mayo Clin Proc. 2006;81:1553–66.

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-52.

Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. J Am Acad Dermatol. 2012; 67:163 e1–12; quiz 75–6.

Castro MCR, Ramos-E-Silva M. Cutaneous infections in the mature patient. Clin Dermatol. 2018;36(2):188-96..

Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004;350: 904-12.

Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore) 2010; 89:217–26.

Pallin DJ, Binder WD, Allen MB, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis 2013;56:1754–62.

Grayson ML, Gibbons GW, Habershaw GM, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683–93.

Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-1406.

Laube S, Farrell AM. Bacterial skin infections in the elderly: Diagnosis and treatment. Drugs Aging. 2002;19:331-42.

Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol. 1998;139:37-40.

Bansal R, Tutrone WD, Weinberg JM. Viral skin infections in the elderly: diagnosis and management. Drugs Aging. 2002;19(7):503-14.

Beutner KR. Clinical management of herpes zoster in the elderly patient. Compr Ther. 1996;6(22):183-6.

Tyring SK. Efficacy of famciclovir in the treatment of herpes zoster. Semin Dermatol. 1996;15:27-31

Degreef H. Famciclovir Herpes Zoster Clinical Study Group. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrob Agents. 1994;4:241-6.

Tyring S, Barbarash R, Nahlik J, et al. Famciclovir for the treatment of acute herpes zoster effects on acute disease and postherpetic neuralgia. Ann Intern Med. 1995;123:89-96.

Beutner K, Friedman DJ, Forszpaniak C, et al. Valciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995;39:1546-53.

Villarreal EC. Current and potential therapies for the treatment of herpesvirus infections. Prog Drug Res. 2001;56:77-120

Cotton DWK, Cooper C, Barrett DF, et al. Severe atypical molluscum contagiosum infection in an immunocompromised host. Br J Dermatol. 1987;116:871-6

Katzman M, Carey JT, Elmets CA, et al. Molluscum contagiosum and the acquired immunodeficiency syndrome: clinical and immunological details of two cases. Br J Dermatol. 1987;116:131-8

Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with HIV infection: a review of 27 patients. J Am Acad Dermatol. 1992;27:583-8.

Meadows KP, Tyring SK, Pavia AT, et al. Resolution of recalcitrant molluscum contagiosum lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol. 1997;133:987-90.

Kauffman CA, Yoshikawa TT. Fungal Infections in Older Adults, Clinical Infectious Diseases. 2001;33(4):550-55.

Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med. 1994;330:263–72.

Kauffman CA, Carver PL. Use of azoles for systemic antifungal therapy. Adv Pharmacol. 1997;39:143–89.

Wey S-J, Chen D-Y. Common cutaneous disorders in the elderly. J Clin Gerontol Geriatrics. 2010;1:36-41.

Nenoff P, Krüger C, Paasch U, et al. Mycology—an update Part 3. Dermatomycoses: Topical and systemic therapy. J Dtsch Dermatol Ges. 2015;13:387-410.

Htwe TH, Mushtaq A, Robinson SB, et al. Infection in the elderly. Infect Dis Clin N Am. 2007;21:711-43.

Roberts WE. Dermatologic problems of older women. Dermatol Clin. 2006;2 4:271-80.

Hansson C, Faergemann J. The effect of antiseptic solutions on microorganisms in venous leg ulcers. Acta Derm Venereol. 1995;75:31-3

Tatnall FM, Leigh IM, Gibson JR. Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacol 1990;3:157-63.

Mulliken JB, Healey NA, Glowacki J. Povidone-iodine and tensile strength of wounds in rats. J Trauma 1980; 20: 323-4

Viljanto J. Disinfection of surgical wounds without inhibition of normal wound healing. Arch Surg 1980; 115: 253-6

Wood B, Rademaker M, Molan P. Manuka honey, a low cost leg ulcer dressing. N Z Med J 1997; 110: 107.

Ashcroft GS, Horan MA, Ferguson MW. The effects of ageing on cutaneous wound healing in mammals. J Anat. 1995;187:1–26.

FalconeM, Paul M, Tiseo G, et al. Considerations for the optimal management of antibiotic therapy in elderly patients. J Glob Antimicrob Resist 2020;22:325–333.

Falcone M, Tiseo G. Skin and soft tissue infections in the elderly. Curr Opin Infect Dis. 2023;36(2):102-8.

Mudge AM, McRae P, Hubbard RE, et al. Hospital-associated complications of older people: a proposed multicomponent outcome for acute care. J Am Geriatr Soc 2019; 67:352–356.

Wackenheim C, Le Mare´ chal M, Pluchart H, et al. Dalbavancin in clinical practice: a particular place for the elderly? Eur J Clin Microbiol Infect Dis 2022; 41:977–979.

Cacopardo B, Cattaneo D, Cortese F, et al. Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios. Expert Rev Anti Infect Ther 2022; 20:997–1004.

Falcone M, Concia E, Giusti M, et al. Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs. Intern Emerg Med 2016; 11:637–648.